Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate and explore the activity of lapatinib or placebo in the two treatment groups with respect to the complete response rate (per RECIST) at six months (24 weeks) from chemoradiation completion in subjects with locally advanced SCCHN.
Critère d'inclusion
- Stage III, IVa, IVb Squamous Cell Carcinoma of the Head & Neck